CRYSTALLINE FORM OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR

The present invention relates to a crystalline form of the heterocyclic compound N-(4-(1-(2-cyanoacetyl)-3-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-yl) cyclopropanecarboxamide as a protein kinase inhibitor. La présente invention concerne une forme cristalline du composé hété...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KIM, Young Ju, KIM, Hanna, LEE, Ye-Lim, HWANG, Do Seok, KIM, Jun, KWEON, Jae Hong
Format:	Patent
Sprache:	eng ; fre ; kor
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a crystalline form of the heterocyclic compound N-(4-(1-(2-cyanoacetyl)-3-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-yl) cyclopropanecarboxamide as a protein kinase inhibitor. La présente invention concerne une forme cristalline du composé hétérocyclique N-(4-(1-(2-cyanoacétyl)-3-méthyl-1,2,3,6-tétrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-yl) cyclopropanecarboxamide en tant qu'inhibiteur de protéine kinase. 본 발명은 단백질 키나제 억제제로서의 헤테로고리 화합물인 N-(4-(1-(2-시아노아세틸)-3-메틸-1,2,3,6-테트라히드로피리딘-4-일)-1H-피롤로[2,3-b]피리딘-6-일) 시클로프로판카복사마이드의 결정형에 관한 것이다.